Erin Kilbury, MA LMHC | |
59-530 Aukauka Rd, Haleiwa, HI 96712-8521 | |
(612) 309-1800 | |
Not Available |
Full Name | Erin Kilbury |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 59-530 Aukauka Rd, Haleiwa, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255076865 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | MHC-949 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Erin Kilbury, MA LMHC 59-530 Aukauka Rd, Haleiwa, HI 96712-8521 Ph: (612) 309-1800 | Erin Kilbury, MA LMHC 59-530 Aukauka Rd, Haleiwa, HI 96712-8521 Ph: (612) 309-1800 |
News Archive
Emerging Healthcare Solutions, Inc. disclosed that the Company has received documents from Stand-By Systems affirming that their revolutionary LIFEDGE prototype is now complete and ready for pilot scale production. EHSI recently executed an option with Stand-By Systems, owner of the new FDA approved SBS 1615 catalytic oxygen generator and associated systems.
The National Institute of Environmental Health Sciences (NIEHS) has awarded a five-year, $1.5 million grant extension to Columbia University's Mailman School of Public Health to fund research into the function of a biomarker for brain injury called Translocator Protein 18 kDa, better known as TSPO, in order to better understand its function in brain injury and inflammation and discover targets for therapy.
Watching the captivating sight of the moon's passing between the sun and Earth, where the moon fully or partially covers the sun, could cause serious and potentially long-term harm to the eye if not viewed properly.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Population growth and increased temperature are the most important explanations to the significant increase of dengue incidence in Singapore since the 1970s. This is shown in a study undertaken by Joacim Rocklöv and his colleagues at the unit of Epidemiology and Global Health at Umeå University, published in the journal Plos One.
› Verified 8 days ago
Connor Ashlyn Parker, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 66-560 Kamehameha Hwy Ste 3b, Haleiwa, HI 96712 Phone: 808-731-2204 | |
Rebecca Taylor Pierce, MSW, LSW, CSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 59-547 Aukauka Pl, Haleiwa, HI 96712 Phone: 808-347-1246 | |
Kenda Lee Mohica, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 59-518 Alapio Rd. Apt. A, Haleiwa, HI 96712 Phone: 808-638-7139 | |
Mrs. Julie Nicole Ray Cohen, LMFT, CSAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 59-327 Pupukea Rd, Haleiwa, HI 96712 Phone: 808-349-1022 | |
Momi Won-hin Damate, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 59-049 Huelo St, Haleiwa, HI 96712 Phone: 808-931-0125 | |
Mr. Mark A Turansky, CSAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 66-526 Kamehameha Hwy Ste Cnew, Haleiwa, HI 96712 Phone: 808-484-1000 Fax: 808-484-1000 |